Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy

被引：0
|
作者：
Cheng, Zhihang [1 ]
Babiker, Salma [1 ]
Lenfestey, Pauline [1 ]
Beare, Nick [1 ]
Pearce, Ian A. [1 ]
机构：
[1] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5002
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy
    Esen, Ebru
    Sizmaz, Selcuk
    Demircan, Nihal
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [22] Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Atik, Alp
    Hu, Yijun
    Yu, Honghua
    Yang, Chun
    Cai, Bin
    Tao, Yijing
    Li, Dongli
    Chen, Yan
    Lu, Li
    Li, Guodong
    Yuan, Ling
    BMC OPHTHALMOLOGY, 2017, 17
  • [23] Half-dose Versus Half-time Photodynamic Therapy for Central Serous Chorioretinopathy
    Liu, Hsin-Yu
    Yang, Chang-Hao
    Yang, Chung-May
    Ho, Tzyy-Chang
    Lin, Chang-Ping
    Hsieh, Yi-Ting
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 167 : 57 - 64
  • [24] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Oiwa, Kazuhiro
    Kataoka, Keiko
    Maruko, Ruka
    Ueno, Shinji
    Ito, Yasuki
    Terasaki, Hiroko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (03) : 260 - 266
  • [25] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Kazuhiro Oiwa
    Keiko Kataoka
    Ruka Maruko
    Shinji Ueno
    Yasuki Ito
    Hiroko Terasaki
    Japanese Journal of Ophthalmology, 2017, 61 : 260 - 266
  • [26] The safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Feenstra, H. M. A.
    Diederen, R. M. H.
    Lamme, M. J. C. M.
    Fauser, S.
    Downes, S. M.
    Schlingemann, R. O.
    Hoyng, C. B.
    van Dijk, E. H. C.
    Boon, C. J. F.
    ACTA OPHTHALMOLOGICA, 2022, 100 : 19 - 19
  • [27] Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Alp Atik
    Yijun Hu
    Honghua Yu
    Chun Yang
    Bin Cai
    Yijing Tao
    Dongli Li
    Yan Chen
    Li Lu
    Guodong Li
    Ling Yuan
    BMC Ophthalmology, 17
  • [28] Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy
    Kim, Yong-Kyu
    Ryoo, Na-Kyung
    Woo, Se Joon
    Park, Kyu Hyung
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (12) : 2063 - 2073
  • [29] Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
    Ratanasukon, Mansing
    Thongthong, Koblarp
    Bhurayanontachai, Patama
    Jirarattanasopa, Pichai
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 87 - 92
  • [30] Half-Dose Verteporfin Photodynamic Therapy (hdPDT) in the Treatment of Central Serous Chorioretinopathy
    Hoehn, F.
    Kretz, F. T. A.
    Beger, I.
    Koch, F.
    Auffarth, G. U.
    Singh, P.
    Deuchler, S.
    Koss, M. J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (07) : 860 - 863
12345